Back to MW Marshall Wace, LLP

PRTAPRTA

Showing 3 of 16 quarters

Position history for MWMarshall Wace, LLP's holdings in Prothena Corporation plc

Yes. Marshall Wace holds 190,834 shares of PRTA (Prothena), worth $1.9M, as of its Q2 2026 13F filing. It increased the position from 44,574 shares in Q1 2026. Marshall Wace has held PRTA since Q4 2025, across 3 quarterly 13F filings.

Current Value

$1.9M

Current Shares

190,834

Total Value Change

+$1.3M

Total Shares Change

+136,056

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
190,834
+328.1%
$1.9M0.0%$9.79
42
2026-Q1
Decreased
44,574
-18.6%
$433,2570.0%$9.72
0
2025-Q4
New
54,778
—
$523,1300.0%$9.55
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used